Besides LPS-induced peritonitis, similar results were obtained in the ConA-induced hepatitis model, where the treatment with GPI, 6AN or clodronate liposomes inhibited inflammatory cytokines (TNF and IL-6), reduced liver damage, and decreased the mortality rate (Supplementary Fig. 7c–f). This evidence concerns the gene IL6 and peritonitis.